Moderna to Present at Upcoming Investor Conferences in March
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 4, 2019--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to cr…
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 4, 2019--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to cr…